Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
NCT ID: NCT02327312
Last Updated: 2022-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
91 participants
INTERVENTIONAL
2014-12-16
2020-08-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical
Implantation of two Trabecular Meshwork stents into the study eye
Stents
Two Trabecular meshwork Micro-Bypass stents into the study eye
Laser
Laser Trabeculoplasty
Laser
Laser Trabeculoplasty
Laser Trabeculoplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stents
Two Trabecular meshwork Micro-Bypass stents into the study eye
Laser
Laser Trabeculoplasty
Laser Trabeculoplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Choroidal detachment, effusion, choroiditis
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glaukos Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerry Stephens, OD
Role: STUDY_CHAIR
Glaukos Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glendale, Arizona, United States
Fayetteville, Arkansas, United States
Hemet, California, United States
Cape Coral, Florida, United States
Elizabeth City, North Carolina, United States
Memphis, Tennessee, United States
Fort Worth, Texas, United States
San Antonio, Texas, United States
Racine, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rolim-de-Moura CR, Paranhos A Jr, Loutfi M, Burton D, Wormald R, Evans JR. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD003919. doi: 10.1002/14651858.CD003919.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GC-004
Identifier Type: -
Identifier Source: org_study_id